Back

Is routine combination of renin-angiotensin system blocker and beta blocker beneficial in low-risk myocardial infarction patients?

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Adjunctive medical therapy in coronary artery disease Adjunctive medical therapy ESC Premium Access ESC Congress 2016

26 More presentations in this session

Presentation thumbnail
Effects of statin therapy on plasma proprotein convertase subtilisin/kexin type 9 and sortilin levels in statin-naive patients with coronary artery disease
Doctor T. Nozue (Yokohama, JP)
Abstract
Presentation thumbnail
Renalguard to prevent acute kidney injury in high risk patients undergoing coronary interventions
Doctor V. Gritti (Cinisello Balsamo, IT)
Abstract Slides
Presentation thumbnail
Benefit of early statin initiation within 48 hours after admission in patients with acute myocardial infarction
Professor M. Kim (Gwangju, KR)
Abstract Slides
Presentation thumbnail
Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies
Doctor Y. Sun (Beijing, CN)
Abstract
Presentation thumbnail
Early donepezil administration as a novel therapy for improved myocardial salvage after reperfused myocardial infarction
Doctor M. Li (Osaka, JP)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Adjunctive medical therapy in coronary artery disease

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources